Turnaround

165 tickers in this investment thesis
Ranks this page's recent reports by score.
TAL Education Group
TAL·Consumer Staples
B ★★★Hold
Current$9.87
Target$11.90
Return+20.6%
Nov 1, 2026

TAL Education's operating recovery, substantial net cash, and low valuation offer upside potential, but Chinese education regulation and volatile investment-related earnings remain significant risks.

Score
74
LKQ Corporation
LKQ·Consumer Discretionary
C ★★Sell
Current$18.56
Nov 1, 2026

LKQ's global aftermarket distribution network and low valuation offer recovery potential, but severe European execution failures, declining earnings, and withdrawn guidance undermine confidence in a sustainable turnaround.

Score
64
Lumen Technologies, Inc.
Current$4.88
Nov 1, 2026

Lumen could benefit from AI-driven enterprise connectivity demand and its digital networking turnaround, but persistent legacy revenue declines, heavy debt, and uncertain recurring cash generation threaten shareholder returns.

Score
44
V.F. Corporation
VFC·Consumer Discretionary
B ★★★Hold
Current$18.30
Target$19.32
Return+5.6%
Nov 1, 2026

V.F. Corporation offers a credible margin and cash-flow turnaround supported by The North Face and Timberland, but persistent Vans weakness and substantial debt limit confidence in sustained earnings recovery.

Score
68
Bio-Rad Laboratories, Inc.
BIO·Healthcare
B ★★★Hold
Current$372.18
Target$366.53
Return-1.5%
Nov 1, 2026

Bio-Rad combines defensible diagnostics franchises and a substantial Sartorius investment with strong liquidity, but weak organic growth, low operating returns, and uncertain asset-value realization constrain its investment appeal.

Score
66
Sirius XM Holdings Inc.
SIRI·Communication Services
B ★★★Hold
Current$29.01
Target$36.30
Return+25.1%
Nov 1, 2026

SiriusXM generates substantial recurring cash flow at an attractive valuation, with falling satellite spending supporting buybacks, but streaming competition and elevated leverage threaten long-term subscriber economics.

Score
74
Baxter International Inc.
BAX·Healthcare
B ★★★Hold
Current$23.00
Target$27.30
Return+18.7%
Nov 1, 2026

Baxter offers a discounted medical-products turnaround supported by recurring hospital demand, recovering cash flow and debt reduction, but elevated leverage and uncertain margin sustainability limit near-term conviction.

Score
72
Aptiv PLC
APTV·Consumer Discretionary
B ★★★Hold
Current$43.93
Target$58.23
Return+32.6%
Nov 1, 2026

Aptiv offers a potentially attractive post-spin recovery through higher-value automotive electronics and low forward earnings valuation, but weak cash conversion and cyclical vehicle demand remain significant obstacles.

Score
65
The Kraft Heinz Company
KHC·Consumer Staples
B ★★★Hold
Current$24.34
Target$26.78
Return+10.0%
Nov 1, 2026

Kraft Heinz offers substantial cash flow, established food brands, and an attractive dividend at a modest valuation, but persistent volume declines and uncertain turnaround execution limit its near-term upside.

Score
65
TELUS Corporation
TU·Communication Services
C ★★Sell
Current$8.87
Nov 1, 2026

TELUS owns a durable Canadian telecom franchise trading below historical cash-flow valuations, but heavy debt, weaker digital services economics, and the dividend reset make its recovery uncertain.

Score
64
Columbia Sportswear Company
COLM·Consumer Discretionary
B ★★★Hold
Current$67.54
Target$72.00
Return+6.6%
Nov 1, 2026

Columbia Sportswear combines established outdoor brands, improving profitability, and meaningful shareholder returns at a reasonable valuation, but weak organic growth, tariff exposure, and inventory risks limit near-term upside.

Score
73
Dana Incorporated
DAN·Consumer Discretionary
B ★★★Hold
Current$23.11
Target$31.50
Return+36.3%
Oct 31, 2026

Dana offers a potentially undervalued automotive-supplier turnaround supported by margin expansion, deleveraging, and Eaton Mobility synergies, but weak cash conversion and merger execution risks constrain conviction.

Score
71